His regimen is associated with a risk of FN of approximately 10 %. In addition, other factors present that may impact the ability to deliver full-dose chemotherapy included severs neutropenia, particularly during the first cycle, age, ethnicity, cardiovascular disease, renal dysfunction, poor nutritional status, and the cancer stage.